We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MRVI market cap is 1.94B. The company's latest EPS is USD -0.4735 and P/E is -16.26.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 191.26M | 204.71M | 79.03M | 71.23M | 64.55M |
| Operating Income | 116.9M | 109.25M | 2.53M | -11.61M | -19.52M |
| Net Income | 44.47M | 37.63M | -67k | -6.54M | -6.46M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 303.1M | 810.49M | 890.8M | 292.23M |
| Operating Income | 119.9M | 554.65M | 574.22M | -31.65M |
| Net Income | 88.97M | 182.04M | 220.21M | -119.03M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 2.25B | 2.28B | 2.32B | 2.26B | 2.27B |
| Total Liabilities | 1.41B | 1.38B | 1.41B | 1.37B | 1.38B |
| Total Equity | 841.67M | 905.24M | 900.64M | 897.64M | 892.28M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.27B | 1.92B | 2.28B | 1.49B |
| Total Liabilities | 1.12B | 1.37B | 1.38B | 697.57M |
| Total Equity | 154.75M | 545.36M | 905.24M | 789.88M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | 436.64M | 535.98M | 85.07M | 104.27M | 118.43M |
| Investing | -249.09M | -267.61M | -69.73M | -93.89M | -109.41M |
| Financing | -121.38M | -187.5M | -19.21M | -62.34M | -61.56M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 152.19M | 368.57M | 535.98M | 126.22M |
| Investing | 6.07M | 105.66M | -267.61M | -122.31M |
| Financing | 53.21M | -159.05M | -187.5M | -61.09M |
| Market Cap | 1.94B |
| Price to Earnings Ratio | -16.26 |
| Price to Sales Ratio | 6.62 |
| Price to Cash Ratio | 3.37 |
| Price to Book Ratio | 2.45 |
| Dividend Yield | - |
| Shares Outstanding | 251.4M |
| Average Volume (1 week) | 1.57M |
| Average Volume (1 Month) | 2.04M |
| 52 Week Change | -41.93% |
| 52 Week High | 16.62 |
| 52 Week Low | 4.52 |
| Spread (Intraday) | 6.28 (47.32%) |
| Company Name | Maravai LifeSciences Holdings Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
